hpayette
New Report Released from the RID Program’s CANCOVID-Preg Project!
The RID Program’s Canadian Surveillance of COVID-19 in Pregnancy: Epidemiology, Maternal and Infant Outcomes (CANCOVID-Preg) Project has just released a new report (Report #7) on some of the most recent updates, key findings and recommendations based on the latest data.
New Publication: “Reliability and validation of an electronic penicillin allergy risk-assessment tool in a pregnant population” Accepted by Allergy, Asthma & Clinical Immunology!
A new publication from a team of authors that includes multiple members of the RID Program, including Dr. Chelsea Elwood, Dr. Julie van Schalkwyk, and Melissa Watt has been accepted by Allergy, Asthma, & Clinical Immunology and will be published in a future issue of the journal!
New Publication: “Maternal-infant transfer of SARS-CoV-2 antibodies following vaccination in pregnancy: A prospective cohort study” published in Vaccine!
A new publication from the RID Program team on the findings of the COVERED Project’s Immune Sub-Study has been published in Vaccine!
New Publication: “Antepartum versus postpartum amoxicillin oral challenge in pregnant patients with a reported penicillin allergy: A two-center prospective cohort study” Published in Acta Obstetricia et Gynecologica Scandinavica!
A new publication authored by RID Program team members entitled “Antepartum versus postpartum amoxicillin oral challenge in pregnant patients with a reported penicillin allergy: A two-center prospective cohort study” has been published in Acta Obstetricia et Gynecologica Scandinavica!
Register Now for the International Workshop on HIV & Women 2025!
Registration is now open for the 2025 iteration of the annual International Workshop on Women & HIV, which is being held from April 11-12, 2025 in Barcelona, Spain as well as virtually!
New Government of Canada Travel Recommendations for Pregnant Women and People Regarding Outbreaks of Oropouche Virus Disease
Due to increased case numbers and particular risks of negative impacts for pregnant women and people of Oropouche Virus Disease, the Government of Canada has released travel recommendations for pregnant women and people going to countries with active outbreaks.
New Publication: “Comparison of Maternal and Infant Outcomes in SARS-CoV-2 Infected Pregnancies and Contemporaneous General Population Pregnancies from British Columbia” published in JOGC!
A new publication entitled “Comparison of Maternal and Infant Outcomes in SARS-CoV-2 Infected Pregnancies and Contemporaneous General Population Pregnancies From British Columbia” authored by RID Program team members has been published in JOGC!
New Practice Bulletin on Listeriosis in Pregnancy Authored by RID Program Team Published by the Canadian Medical Association Journal!
In response to the Listeria-related recalls of plant-based milks in Canada, four members of the RID program wrote and have now published a new practice bulletin on listeriosis in pregnancy
New SOGC Statement “RSV Immunization to Prevent Infant RSV Infection” Authored by Multiple Members of the RID Program has been Published!
A new statement from The Society of Obstetricians and Gynecologists of Canada (SOGC) on RSV immunization to Prevent RSV Infection has been published, authored by multiple members of the RID program team including Dr. Jeffrey Wong, Dr. Deborah Money, Dr. Chelsea Elwood and Dr. Julie van Schalkwyk!
Congratulations Dr. Mel Krajden on receiving the John G. FitzGerald Award from the Canadian Association for Clinical Microbiology and Infectious Diseases!
The RID Program team would like to offer our sincerest congratulations to Dr. Mel Krajden, who has been awarded the John G. FitzGerald Award from the Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID)!